Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01401439 · ClinicalTrials.gov registry record
Assessment of Fat Free Mass Index and Its Impact on Health in Children With Cystic Fibrosis
A clinical trial, sponsored by University of Arkansas.
- Completed
- Registry status
- 24
- Enrollment target
NCT01401439: Completed study, sponsored by University of Arkansas.
NCT01401439 is a clinical trial that has completed, run by University of Arkansas. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01401439 has completed, sponsored by University of Arkansas.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
The purpose of this study is to find out whether measurement of body composition has a prognostic value on clinical and overall outcome in pediatric patients with cystic fibrosis.
Primary Outcome
Compare Dual Energy X-Ray Absorptiometry (DEXA) analysis to GAIA device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2012-06 |
| Est. Completion | 2016-07 |
What the finished NCT01401439 record still lists
NCT01401439 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 24 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01401439 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01401439 about?
NCT01401439 is a clinical study titled "Assessment of Fat Free Mass Index and Its Impact on Health in Children With Cystic Fibrosis". The purpose of this study is to find out whether measurement of body composition has a prognostic value on clinical and overall outcome in pediatric patients with cystic fibrosis.
What is the current status of trial NCT01401439?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2012-06. Estimated completion is 2016-07.
Who is sponsoring clinical trial NCT01401439?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia